Funder
Japan Society for the Promotion of Science
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology
Reference39 articles.
1. Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects;Jenkins;Aliment Pharmacol Ther,2015
2. Effects of proton pump inhibitors, esomeprazole and vonoprazan, on the disposition of proguanil, a CYP2C19 substrate, in healthy volunteers;Funakoshi;Br J Clin Pharmacol,2019
3. Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms;Coller;Br J Clin Pharmacol,1999
4. Comparative study of effects of vonoprazan and esomeprazole on antiplatelet function of clopidogrel or prasugrel in relation to CYP2C19 genotype;Kagami;Clin Pharmacol Ther,2018
5. Genetic polymorphisms and the impact of a higher clopidogrel dose regimen on active metabolite exposure and antiplatelet response in healthy subjects;Simon;Clin Pharmacol Ther,2011